Summary
CVS Health Corporation reported solid revenue growth for the second quarter and first half of 2021, driven by increases across all its major segments, particularly Pharmacy Services and Retail/LTC. Total revenues rose 11.1% for the quarter and 7.3% year-to-date compared to the prior year. While overall revenues were strong, operating income saw a slight decline of 7.6% for the quarter and 2.9% year-to-date, primarily due to the normalization of healthcare utilization in the Health Care Benefits segment as the impact of the COVID-19 pandemic shifted from the prior year's lows. The company demonstrated resilience with strong performance in its Pharmacy Services segment, benefiting from improved purchasing economics and increased claims volume. The Retail/LTC segment also showed significant revenue growth, bolstered by prescription volume and COVID-19 related services like vaccinations and testing. Despite these positive operational trends, investors should note the decrease in operating income driven by the comparison to a pandemic-influenced prior year and the ongoing investments in growth and operational enhancements.
Financial Highlights
55 data points| Revenue | $72.62B |
| Cost of Revenue | $43.52B |
| Gross Profit | $29.10B |
| Operating Expenses | $68.29B |
| Operating Income | $4.33B |
| Interest Expense | $636.00M |
| Net Income | $2.78B |
| EPS (Basic) | $2.11 |
| EPS (Diluted) | $2.10 |
| Shares Outstanding (Basic) | 1.32B |
| Shares Outstanding (Diluted) | 1.33B |
Key Highlights
- 1Total revenues increased 11.1% to $72.6 billion for the three months ended June 30, 2021, and 7.3% to $141.7 billion for the six months ended June 30, 2021, compared to the prior year.
- 2Operating income decreased by 7.6% to $4.3 billion for the three months ended June 30, 2021, and by 2.9% to $7.9 billion for the six months ended June 30, 2021, compared to the prior year.
- 3The Health Care Benefits segment experienced a significant decrease in operating income, primarily due to the return of normalized healthcare utilization and the repeal of the Health Insurer Fee (HIF) in 2021, impacting year-over-year comparisons.
- 4The Pharmacy Services segment showed strong growth, with total revenues up 9.8% for the quarter and 6.8% year-to-date, driven by increased claims volume and improved purchasing economics.
- 5The Retail/LTC segment reported robust revenue growth of 14.2% for the quarter and 8.1% year-to-date, significantly boosted by prescription volume, COVID-19 vaccinations, and diagnostic testing.
- 6Net income attributable to CVS Health was $2.8 billion for the three months ended June 30, 2021, a decrease of 6.5% from the prior year, and $5.0 billion for the six months ended June 30, 2021, a slight increase of 0.5%.